<unk>  is an anticonvulsant that is FDA approved for the treatment of epilepsy in patients 16 years of age and older with partial-onset seizures.   Common adverse reactions include somnolence/sedation, dizziness, fatigue, and nausea/vomiting (5%).
Brivaracetam
Piracetam
Oxiracetam
Tiagabine
Ezogabine
Levetiracetam 
Retigabine
Mesuximide